Tofogliflozin, Catalog: B2083

IN STOCK!
US$0.00

(1S,3'R,4'S,5'S,6'R)-6-[(4-Ethylphenyl)methyl]-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro[isobenzofuran-1(3H),2'-[2H]pyran]-3',4',5'-triol; CSG452

PRODUCT SUMMARY

Alternate Names (1S,3'R,4'S,5'S,6'R)-6-[(4-Ethylphenyl)methyl]-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro[isobenzofuran-1(3H),2'-[2H]pyran]-3',4',5'-triol; CSG452

Appearance White solid

CAS # 903565-83-3

Molecular Formula C₂₂H₂₆O₆

Molecular Weight 386.44

Purity ≥ 98%

Solubility DMSO

SMILES CCC1=CC=C(C=C1)CC2=CC3=C(COC34C(C(C(C(O4)CO)O)O)O)C=C2

InChi InChI=1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1

InChi Key VWVKUNOPTJGDOB-BDHVOXNPSA-N

PubChem CID 46908929

MDL Number MFCD27665464

Storage Conditions -20°C

Shipping Conditions Gel Pack

Usage For Research Use Only! Not For Use in Humans.

Handling Do not take it internally. Wear a glove and mask when handling the product. Protect from air and moisture.

DESCRIPTION

Tofogliflozin is a potent, and highly selective SGLT2 inhibitor that has been shown to improve glycemic control in diabetic mice and rats. Potential drug for treatment of type 2 diabetes.